Krystal Biotech, Inc. KRYS Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s quick ratio?
- Krystal Biotech, Inc. (KRYS) reported quick ratio of 9.1× in Q1 2026.
- How has Krystal Biotech, Inc.'s quick ratio changed year-over-year?
- Krystal Biotech, Inc.'s quick ratio decreased by 2.2% year-over-year, from 9.3× to 9.1×.
- What is the long-term trend for Krystal Biotech, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s quick ratio has grown at a -11.7% compound annual growth rate (CAGR), from 17.8× to 9.6×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.